Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies

Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies

<i>Background and Aims</i>: Statins are the first-line medication to treating hypercholesterolemia. Several studies have investigated the impact of statins on the risk of hepatocellular carcinoma (HCC). However, the extent to which statins may prevent HCC remains uncertain. Therefore, we...

Full description

Bibliographic Details
Main Authors: Md. Mohaimenul Islam, Tahmina Nasrin Poly, Bruno Andreas Walther, Hsuan-Chia Yang, Yu-Chuan (Jack) Li
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Cancers
Subjects:
hepatocellular carcinoma
liver cancer
liver cirrhosis
fatty liver
liver fibrosis
statins
Online Access:https://www.mdpi.com/2072-6694/12/3/671

Internet

https://www.mdpi.com/2072-6694/12/3/671

Similar Items